649 related articles for article (PubMed ID: 33445768)
1. From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.
Wu CY; Yang HY; Luo SF; Lai JH
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445768
[TBL] [Abstract][Full Text] [Related]
2. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.
Verheul MK; Böhringer S; van Delft MAM; Jones JD; Rigby WFC; Gan RW; Holers VM; Edison JD; Deane KD; Janssen KMJ; Westra J; Brink M; Rantapää-Dahlqvist S; Huizinga TWJ; van der Helm-van Mil AHM; van der Woude D; Toes REM; Trouw LA
Arthritis Rheumatol; 2018 Nov; 70(11):1721-1731. PubMed ID: 29781231
[TBL] [Abstract][Full Text] [Related]
3. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW
Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250
[TBL] [Abstract][Full Text] [Related]
4. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
[TBL] [Abstract][Full Text] [Related]
6. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D
Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody and metalloproteinase activity in early arthritis.
Ponikowska M; Świerkot J; Nowak B; Korman L; Wiland P
Clin Rheumatol; 2019 Mar; 38(3):827-834. PubMed ID: 30406565
[TBL] [Abstract][Full Text] [Related]
8. Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis.
Sahlström P; Hansson M; Steen J; Amara K; Titcombe PJ; Forsström B; Stålesen R; Israelsson L; Piccoli L; Lundberg K; Klareskog L; Mueller DL; Catrina AI; Skriner K; Malmström V; Grönwall C
Arthritis Rheumatol; 2020 Oct; 72(10):1643-1657. PubMed ID: 32501655
[TBL] [Abstract][Full Text] [Related]
9. Anti-Carbamylated Fibrinogen Antibodies Might Be Associated With a Specific Rheumatoid Phenotype and Include a Subset Recognizing
Brevet P; Lattard C; Guillou C; Rottenberg P; Fardellone P; Le-Loët X; Lequerré T; Cosette P; Boyer O; Fréret M; Vittecoq O
Front Immunol; 2021; 12():733511. PubMed ID: 34691039
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies.
Reed E; Jiang X; Kharlamova N; Ytterberg AJ; Catrina AI; Israelsson L; Mathsson-Alm L; Hansson M; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2016 May; 18(1):96. PubMed ID: 27145822
[TBL] [Abstract][Full Text] [Related]
11. Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis.
Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Hamann D; van Schaardenburg D; Toes RE; Trouw LA
Ann Rheum Dis; 2014 Apr; 73(4):780-3. PubMed ID: 24336334
[TBL] [Abstract][Full Text] [Related]
12. Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.
Regueiro C; Nuño L; Ortiz AM; Peiteado D; Villalba A; Pascual-Salcedo D; Martínez-Feito A; González-Alvaro I; Balsa A; González A
Sci Rep; 2017 Sep; 7(1):12023. PubMed ID: 28931886
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.
Shi J; Knevel R; Suwannalai P; van der Linden MP; Janssen GM; van Veelen PA; Levarht NE; van der Helm-van Mil AH; Cerami A; Huizinga TW; Toes RE; Trouw LA
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17372-7. PubMed ID: 21987802
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis.
de Brito Rocha S; Baldo DC; Andrade LEC
Adv Rheumatol; 2019 Jan; 59(1):2. PubMed ID: 30657101
[TBL] [Abstract][Full Text] [Related]
15. Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis.
Amkreutz JAMP; de Moel EC; Theander L; Willim M; Heimans L; Nilsson JÅ; Karlsson MK; Huizinga TWJ; Åkesson KE; Jacobsson LTH; Allaart CF; Turesson C; van der Woude D
Arthritis Rheumatol; 2021 Jun; 73(6):921-930. PubMed ID: 33314699
[TBL] [Abstract][Full Text] [Related]
16. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis.
Bugatti S; Bogliolo L; Vitolo B; Manzo A; Montecucco C; Caporali R
Arthritis Res Ther; 2016 Oct; 18(1):226. PubMed ID: 27716332
[TBL] [Abstract][Full Text] [Related]
17. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.
Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E
Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800
[TBL] [Abstract][Full Text] [Related]
18. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028
[TBL] [Abstract][Full Text] [Related]
19. The pathogenic potential of autoreactive antibodies in rheumatoid arthritis.
Bax M; Huizinga TW; Toes RE
Semin Immunopathol; 2014 May; 36(3):313-25. PubMed ID: 24763532
[TBL] [Abstract][Full Text] [Related]
20. MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF.
Boeters DM; Nieuwenhuis WP; Verheul MK; Newsum EC; Reijnierse M; Toes RE; Trouw LA; van der Helm-van Mil AH
Arthritis Res Ther; 2016 Aug; 18():179. PubMed ID: 27485323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
